69292-015 : Ganciclovir 1.5 mg/g Ophthalmic Gel


NDC69292-015
Labeler: Amici Pharmaceuticals LLC
Product Type: Human Prescription Drug
Drug Name:  Ganciclovir
Dosage Form: Ophthalmic Gel
Application #: NDA022211
Rev. Date: 


NDC Package Codes:

  • 69292-015-35: 1 TUBE, WITH APPLICATOR IN 1 CARTON (69292‑015‑35) > 5 G IN 1 TUBE, WITH APPLICATOR

Active Ingredients:

  • Ganciclovir

Dosage Strength:

  • 1.5 mg/g

Pharmaceutical Classes:

  • Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
  • DNA Polymerase Inhibitors [MoA]
  • Nucleoside Analog [Chemical/Ingredient]
  • Nucleoside Analog Antiviral [EPC]

Related Products:

Based on records with the same trade name.
  • 0143-9299 Ganciclovir 50 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Hikma Pharmaceuticals USA Inc.
  • 14335-030 Ganciclovir 50 mg/ml Intraventricular Injection, Powder, Lyophilized, for Solution by Hainan Poly Pharm. Co., Ltd.
  • 25021-185 Ganciclovir 50 mg/ml Intravenous Injection, Solution by Sagent Pharmaceuticals
  • 42023-173 Ganciclovir 500 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Par Pharmaceutical, Inc.
  • 51754-2500 Ganciclovir 2 mg/ml Intravenous Injection, Solution by Exela Pharma Sciences, LLC
  • 51817-171 Ganciclovir 500 mg/10ml Intravenous Injection, Solution by Pharmascience Inc.
  • 55390-016 Ganciclovir 50 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Bedford Laboratories
  • 63304-636 Ganciclovir 250 mg/1 Oral Capsule by Ranbaxy Pharmaceuticals Inc.
  • 63304-637 Ganciclovir 500 mg/1 Oral Capsule by Ranbaxy Pharmaceuticals Inc.
  • 63323-315 Ganciclovir 500 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by App Pharmaceuticals, LLC
  • 70436-089 Ganciclovir 50 mg/ml Intraventricular Injection, Powder, Lyophilized, for Solution by Slate Run Pharmaceuticals

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 69292-015 QR Code

< Prev: 69291-9020Next: 69292-206 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.